How should investors evaluate TG Therapeutics Inc. (NASDAQ:TGTX)?

Stocks of TG Therapeutics Inc. (NASDAQ:TGTX) traded higher last session on Wall Street, down -0.19% to $10.53. According to the data, TG Therapeutics Inc. (NASDAQ:TGTX) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and […]

TG Therapeutics Inc. [TGTX] attracts people because of its fundamentals

TG Therapeutics Inc. (NASDAQ:TGTX) shares traded -4.46% lower at $9.65 on Wall Street last session. In accordance with the data, 9 analysts cover TG Therapeutics Inc. (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $41.00 and a low of $6.00, […]

Does TG Therapeutics Inc. (NASDAQ:TGTX) have deteriorating prospects?

TG Therapeutics Inc. (NASDAQ:TGTX) shares traded -1.65% lower at $20.28 on Wall Street last session. In accordance with the data, 9 analysts cover TG Therapeutics Inc. (NASDAQ:TGTX). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $42.00 and a low of $6.00, […]

There’s Still Time to Buy TG Therapeutics Inc. (NASDAQ:TGTX) Stock

In yesterday’s Wall Street session, TG Therapeutics Inc. (NASDAQ:TGTX) shares traded at $24.84, up 3.03% from the previous session. 9 analysts cover TG Therapeutics Inc. (NASDAQ:TGTX), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $42.00 and a […]